Bisolvon Linctus Mucolytic Syrup for Fatty Cough 250 ml 4 mg/5 ml

Bisolvon Linctus is a Bromhexine-based syrup with mucolytic action suitable for adults, adolescents and children. Useful in case of acute and chronic respiratory diseases, with cough and phlegm production .

Bisolvon Linctus is concentrated in the bronchial and lung tissue, where phlegm is present. Here it acts with its triple effect:

• It liquefies mucus deposits in the respiratory tract.
• It helps to expectorate and eliminate phlegm.
  
• Calms the cough.

Bisolvon Linctus syrup contains neither sucrose nor fructose and can be administered to diabetics.

Dosage and method of use of Bisolvon Linctus Mucolytic Syrup Oily Cough 250 ml 4 mg/5 ml

How to take Levotuss Syrup?

Adults: take 5 - 10 ml of Bisolvon Linctus Syrup 4 mg/5 ml using the conical dispenser, 3 times a day

Children over 2 years of age: 2.5 - 5 ml of Bisolvon Linctus Syrup 4 mg/5 ml using the conical dispenser, 3 times a day

The syrup can be administered to diabetics and children over 2 years old, it does not contain fructose or sucrose. Do not exceed the recommended doses. We recommend taking Bisolvon Linctus Syrup after meals.

Active ingredients and excipients Bisolvon Linctus Mucolytic Syrup Oily Cough 250 ml 4 mg/5 ml

5 ml of Bisolvon Linctus Syrup 4 mg/5 ml contain:

Active ingredient : bromhexine hydrochloride 4 mg (equivalent to bromhexine 3.65 mg);

Excipients : benzoic acid, liquid maltitol, sucralose, chocolate flavouring, cherry flavouring, levomenthol, purified water.

Contraindications Bisolvon Linctus Mucolytic Syrup Oily Cough 250 ml 4 mg/5 ml

Bisolvon Linctus Mucolytic Syrup 250 ml 4 mg/5 ml is contraindicated in case of:

• Hypersensitivity to the active substance or to any of the excipients.
• Children under 2 years of age.
• Feeding time.
• Hereditary conditions which may be incompatible with one of the excipients.

Warnings Bisolvon Linctus Mucolytic Syrup Oily Cough 250 ml 4 mg/5 ml

In very few cases, serious skin lesions such as Stevens Johnson syndrome and toxic epidermal necrolysis (TEN) have been observed simultaneously with the administration of expectorants such as bromhexine. Most of these could be explained by the severity of underlying diseases or by other drugs taken at the same time.

Additionally, in the early stages of Stevens Johnson syndrome or toxic epidermal necrolysis (TEN), patients may initially experience nonspecific flu-like symptoms, such as fever, chills, rhinitis, cough, and sore throat. Because of these misleading symptoms, symptomatic treatment with cough and cold therapy may be undertaken. Therefore, if new lesions of the skin or mucous membranes occur, consult your doctor immediately and discontinue treatment with bromhexine as a precaution.

Mucolytics can induce bronchial obstruction in children under 2 years of age. In fact, the drainage capacity of bronchial mucus is limited in this age group, due to the physiological characteristics of the respiratory tract. They must therefore not be used in children under 2 years of age (see paragraph "When it should not be used").

Side effects Bisolvon Linctus Mucolytic Syrup Oily Cough 250 ml 4 mg/5 ml

Bisolvon Linctus Mucolytic Syrup may cause side effects:

• Immune system, skin, subcutaneous tissue, respiratory system, thoracic and mediastinal disorders: frequency not known: anaphylactic reaction including anaphylactic shock, angioedema, bronchospasm, urticaria, pruritus; rare frequency: skin rash and other hypersensitivity reactions.
• Gastrointestinal disorders: uncommon frequency: nausea, vomiting, diarrhea and upper abdominal pain.

Compliance with the instructions contained in the leaflet reduces the risk of side effects. These side effects are generally transient. However, when they occur it is advisable to consult your doctor or pharmacist.

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please inform your doctor or pharmacist.

Overdose Bisolvon Linctus Mucolytic Syrup Oily Cough 250 ml 4 mg/5 ml
To date, no specific symptoms of overdose have ever been reported in humans. In reported cases of accidental overdose and/or medication errors, the symptoms observed correspond to the known side effects of Bisolvon at recommended dosages, and symptomatic treatment may be necessary. In case of accidental ingestion of an excessive dose of Bisolvon, immediately notify your doctor or contact the nearest hospital.

Interactions Bisolvon Linctus Syrup and other drugs

No interactions with other medicinal products have been reported.

Pregnancy and breastfeeding Bisolvon Linctus Mucolytic Syrup Oily Cough 250 ml 4 mg/5 ml

Can I take Bisolvon Linctus Syrup while pregnant or breastfeeding?

There is limited data on the use of bromhexine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity.

As a precautionary measure, it is preferable to avoid the use of Bisolvon during pregnancy.

It is not known whether bromhexine and its metabolites pass into human milk. Available pharmacodynamic and toxicology data in animals have shown excretion of bromhexine and its metabolites in breast milk. A risk to breastfed infants cannot be excluded.

Bisolvon should not be used during breastfeeding . Consult your doctor if you suspect you are pregnant or want to plan a pregnancy.

Fertility : No studies have been conducted to investigate the effects on human fertility. Based on preclinical experience there are no indications of possible effects on fertility following the use of bromhexine.

Expiration and storage of Bisolvon Linctus Mucolytic Syrup Oily Cough 250 ml 4 mg/5 ml

How to store Bisolvon Linctus Syrup?

The expiry date of Bisolvon Linctus Syrup 250 ml 4 mg/5 ml is indicated on the package. After first opening the 250 ml 4 mg/5 ml bottle, the product must be consumed within 12 months.